Novavax combined influenza/Covid-19 vaccine shows promise in preclinical study
Reuters
10 May, 2021, 07:25 pm
Last modified: 10 May, 2021, 07:28 pm
Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Novavax logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
Novavax Inc said on Monday its combined flu and Covid-19 vaccine produced functional antibodies against influenza and the coronavirus in a preclinical study
While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.